医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Emerging biomarkers in inflammatory bowel disease (embark) study identifies fecal calprotectin, serum mmp9, and serum il-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging

广告
第一作者: Faubion,W.A.
作者单位: Division of Gastroenterology Hepatology, and Nutrition, University of Utah, Salt Lake City, UT [1] Division of Digestive Diseases and Nutrition, University of Kentucky, Lexington, KY, United States [2] Atlanta Gastroenterology Specialists, Atlanta, GA, United States [3] Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN [4] Robarts Research Institute, University of Western Ontario, London, ON, Canada [5] Department of Medicine, Section of Digestive Diseases, Yale University, New Haven, CT, United States [6] Research and Early Development, Genentech, South San Francisco, CA, United States [7] Department of Radiology, Mayo Clinic, Rochester, MN, United States [8] Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States [9] Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, United [10]
发布时间 2014-02-28
提交
  • 浏览1
The American Journal of Gastroenterology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷